Literature DB >> 11323029

The interaction of the calcium- and integrin-binding protein (CIBP) with the coagulation factor VIII.

X Fang1, C Chen, Q Wang, J Gu, C Chi.   

Abstract

The gene encoding the C-terminal part of A1-domain of human blood coagulation factor VIII (FVIII), a 110-amino acid fragment from Ala(227) to Arg(336), namely A1(Delta1-226), was cloned and used as a 'bait' to screen a protein, which might interact with this region by using the yeast two-hybrid system. A gene coding for a related protein of FVIII named calcium- and integrin-binding protein (CIBP) was isolated from the normal human liver cDNA library. The results were confirmed by using the mammalian two-hybrid system and coimmunoprecipitation. The gene coding for CIBP was constructed by polymerase chain reaction (PCR) and then cotransfected with the B-domain-deleted FVIII gene into mammalian cell lines using the expression vector of FVIII for transient or stable expression. The culture supernatant was collected and analyzed both by enzyme-linked immunosorbent assay (ELISA) for FVIII antigen level and by one-stage method for procoagulant activity. Coexpressed with CIBP, the antigen level of FVIII in the mammalian cell line baby hamster kidney (BHK) cells increased up to about 170% and its bioactivity rose accordingly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323029     DOI: 10.1016/s0049-3848(01)00229-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  Advancements in gene transfer-based therapy for hemophilia A.

Authors:  Christopher B Doering; H Trent Spencer
Journal:  Expert Rev Hematol       Date:  2009-12       Impact factor: 2.929

2.  Calcium- and magnesium-dependent interactions between calcium- and integrin-binding protein and the integrin alphaIIb cytoplasmic domain.

Authors:  Aaron P Yamniuk; Hans J Vogel
Journal:  Protein Sci       Date:  2005-05-09       Impact factor: 6.725

Review 3.  CIB1: a small protein with big ambitions.

Authors:  Tina M Leisner; Thomas C Freeman; Justin L Black; Leslie V Parise
Journal:  FASEB J       Date:  2016-04-26       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.